BOSTON SCIENTIFIC CORPORATION Segment Reporting Other Item Amount
BOSTON SCIENTIFIC CORPORATION (BSX) reported Segment Reporting Other Item Amount of $11.00 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-03.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2025-11-03
- BOSTON SCIENTIFIC CORPORATION segment reporting other item amount for the quarter ending 2025-09-30 was $11.00M, a 175.00% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION segment reporting other item amount for the quarter ending 2025-06-30 was $14.00M, a 55.56% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION segment reporting other item amount for the quarter ending 2025-03-31 was $11.00M, a 22.22% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION segment reporting other item amount for the quarter ending 2024-12-31 was $10.00M.
- BOSTON SCIENTIFIC CORPORATION segment reporting other item amount for fiscal 2024 was $33.00M, a 23.26% decline from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION segment reporting other item amount for fiscal 2023 was $43.00M, a 4.44% decline from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION segment reporting other item amount for fiscal 2022 was $45.00M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2025-09-30 | $11.00M 10-Q · filed 2025-11-03 | $25.00M derived: sum of 2 quarters · filed 2025-11-03 | $37.00M 10-Q · filed 2025-11-03 | $46.00M derived: sum of 4 quarters · filed 2025-11-03 |
| 2025-06-30 | $14.00M 10-Q · filed 2025-08-01 | $25.00M 10-Q · filed 2025-08-01 | $35.00M derived: sum of 3 quarters · filed 2025-08-01 | $39.00M derived: sum of 4 quarters · filed 2025-11-03 |
| 2025-03-31 | $11.00M 10-Q · filed 2025-05-01 | $21.00M derived: sum of 2 quarters · filed 2025-05-01 | $25.00M derived: sum of 3 quarters · filed 2025-11-03 | $34.00M derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $14.00M derived: sum of 2 quarters · filed 2025-11-03 | $23.00M derived: sum of 3 quarters · filed 2025-11-03 | $33.00M 10-K · filed 2025-02-18 |
| 2024-09-30 | $4.00M 10-Q · filed 2025-11-03 | $13.00M derived: sum of 2 quarters · filed 2025-11-03 | $23.00M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $9.00M 10-Q · filed 2025-08-01 | $18.00M 10-Q · filed 2025-08-01 | ||
| 2024-03-31 | $9.00M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $43.00M 10-K · filed 2025-02-18 | |||
| 2022-12-31 | $45.00M 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |